Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
36.87
-1.18 (-3.10%)
Mar 14, 2025, 11:29 AM EDT - Market open

Legend Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Market Capitalization
6,7715,96910,9388,3577,1753,735
Upgrade
Market Cap Growth
-45.43%-45.43%30.89%16.46%92.11%-
Upgrade
Enterprise Value
6,2165,1049,8357,6956,6133,163
Upgrade
Last Close Price
38.0532.5460.1749.9246.6128.16
Upgrade
PS Ratio
11.099.5238.3671.42104.2549.80
Upgrade
PB Ratio
6.725.748.7411.239.376.25
Upgrade
P/TBV Ratio
5.755.758.7711.289.436.28
Upgrade
EV/Sales Ratio
9.918.1434.4965.7696.0842.17
Upgrade
Debt / Equity Ratio
0.340.340.260.380.160.01
Upgrade
Asset Turnover
0.360.360.180.100.070.15
Upgrade
Inventory Turnover
29.9129.9135.3566.27176.58157.02
Upgrade
Quick Ratio
4.494.496.773.594.115.09
Upgrade
Current Ratio
4.624.626.923.694.145.14
Upgrade
Return on Equity (ROE)
-15.45%-15.45%-51.94%-59.11%-59.19%-71.12%
Upgrade
Return on Assets (ROA)
-10.84%-10.84%-17.39%-23.37%-26.75%-28.32%
Upgrade
Return on Capital (ROIC)
-12.84%-12.84%-21.19%-29.86%-33.05%-37.86%
Upgrade
Earnings Yield
-2.53%-2.97%-4.74%-5.34%-5.62%-7.13%
Upgrade
FCF Yield
-2.26%-2.65%-3.78%-2.66%-3.35%-6.67%
Upgrade
Buyback Yield / Dilution
-3.84%-3.84%-10.71%-12.91%-19.21%-18.15%
Upgrade
Total Shareholder Return
-3.84%-3.84%-10.71%-12.91%-19.21%-18.15%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.